Immunotherapy for Malignant Glioma: Current Status and Future Directions

被引：130

作者：

Wang, Hongxiang ^{[1
]}

Xu, Tao ^{[1
]}

Huang, Qilin ^{[1
,2
]}

Jin, Weilin ^{[3
,4
]}

Chen, Juxiang ^{[1
]}

机构：

[1] Second Mil Med Univ, Changzheng Hosp, Shanghai Inst Neurosurg, Dept Neurosurg, Shanghai 200003, Peoples R China

[2] Gen Hosp Cent Theater Command Chinese Peoples Lib, Dept Neurosurg, Wuhan 430070, Peoples R China

[3] Shanghai Jiao Tong Univ, Inst Nano Biomed & Engn, Key Lab Thin Film & Microfabricat Technol, Minist Educ,Dept Instrument Sci & Engn,Sch Elect, Shanghai 200240, Peoples R China

[4] Guilin Med Univ, Affiliated Hosp, Ctr Translat Med, Guilin 541004, Peoples R China

来源：

TRENDS IN PHARMACOLOGICAL SCIENCES | 2020年 / 41卷 / 02期

基金：

中国国家自然科学基金;

关键词：

LONG-TERM SURVIVAL; T-CELLS; MACROPHAGE POLARIZATION; TUMOR MICROENVIRONMENT; CHECKPOINT BLOCKADE; MISMATCH REPAIR; STEM-CELLS; GLIOBLASTOMA; TEMOZOLOMIDE; COMBINATION;

D O I：

10.1016/j.tips.2019.12.003

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Glioma is the most common intracranial primary malignancy, with limited treatment options and a poor overall survival (OS). Immunotherapy has been used successfully in various cancers, leading to the development of similar therapies that activate the patient's immune system to eliminate glioma. In this review, we introduce the diverse immunotherapeutic approaches available for treating glioma, highlighting the successes and challenges resulting from current clinical trials. Additionally, we emphasize the effect of multiple clinical factors on immunotherapy to help optimize individualized treatment regimens. Finally, we also highlight several novel concepts and technologies that could be used to design new and/or improve existing immunotherapies. Such approaches will delineate a new blueprint for glioma treatment.

引用

页码：123 / 138

页数：16

共 105 条

[41] Targeted calcium influx boosts cytotoxic T lymphocyte function in the tumour microenvironment [J].

Kim, Kyun-Do ;

Bae, Seyeon ;

Capece, Tara ;

Nedelkovska, Hristina ;

De Rubio, Rafael G. ;

Smrcka, Alan V. ;

Jun, Chang-Duk ;

Jung, Woojin ;

Park, Byeonghak ;

Kim, Tae-Il ;

Kim, Minsoo .

NATURE COMMUNICATIONS, 2017, 8

[42] Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomase [J].

Kohanbash, Gary ;

Carrera, Diego A. ;

Shrivastav, Shruti ;

Ahn, Brian J. ;

Jahan, Naznin ;

Mazor, Tali ;

Chheda, Zinal S. ;

Downey, Kira M. ;

Watchmaker, Payal B. ;

Beppler, Casey ;

Warta, Rolf ;

Amankulor, Nduka A. ;

Herold-Mende, Christel ;

Costello, Joseph F. ;

Okada, Hideho .

JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (04) :1425-1437

[43] Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations [J].

Kugel, Curtis H., III ;

Douglass, Stephen M. ;

Webster, Marie R. ;

Kaur, Amanpreet ;

Liu, Qin ;

Yin, Xiangfan ;

Weiss, Sarah A. ;

Darvishian, Farbod ;

Al-Rohil, Rami N. ;

Ndoye, Abibatou ;

Behera, Reeti ;

Alicea, Gretchen M. ;

Ecker, Brett L. ;

Fane, Mitchell ;

Allegrezza, Michael J. ;

Svoronos, Nikolaos ;

Kumar, Vinit ;

Wang, Daniel Y. ;

Somasundaram, Rajasekharan ;

Hu-Lieskovan, Siwen ;

Ozgun, Alpaslan ;

Herlyn, Meenhard ;

Conejo-Garcia, Jose R. ;

Gabrilovich, Dmitry ;

Stone, Erica L. ;

Nowicki, Theodore S. ;

Sosman, Jeffrey ;

Rai, Rajat ;

Carlino, Matteo S. ;

Long, Georgina V. ;

Marais, Richard ;

Ribas, Antoni ;

Eroglu, Zeynep ;

Davies, Michael A. ;

Schilling, Bastian ;

Schadendorf, Dirk ;

Xu, Wei ;

Amaravadi, Ravi K. ;

Menzies, Alexander M. ;

McQuade, Jennifer L. ;

Johnson, Douglas B. ;

Osman, Iman ;

Weeraratna, Ashani T. .

CLINICAL CANCER RESEARCH, 2018, 24 (21) :5347-5356

[44] PD-1 inhibition has only limited clinical benefit in patients with recurrent high-grade glioma [J].

Kurz, Sylvia C. ;

Cabrera, Lais P. ;

Hastie, David ;

Huang, Raymond ;

Unadkat, Prashin ;

Rinne, Mikael ;

Nayak, Lakshmi ;

Lee, Eudocia Q. ;

Reardon, David A. ;

Wen, Patrick Y. .

NEUROLOGY, 2018, 91 (14) :E1355-E1359

[45] Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma [J].

Lang, Frederick F. ;

Conrad, Charles ;

Gomez-Manzano, Candelaria ;

Yung, W. K. Alfred ;

Sawaya, Raymond ;

Weinberg, Jeffrey S. ;

Prabhu, Sujit S. ;

Rao, Ganesh ;

Fuller, Gregory N. ;

Aldape, Kenneth D. ;

Gumin, Joy ;

Vence, Luis M. ;

Wistuba, Ignacio ;

Rodriguez-Canales, Jaime ;

Villalobos, Pamela A. ;

Dirven, Clemens M. F. ;

Tejada, Sonia ;

Valle, Ricardo D. ;

Alonso, Marta M. ;

Ewald, Brett ;

Peterkin, Joanna J. ;

Tufaro, Frank ;

Fueyo, Juan .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (14) :1419-+

[46] Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity [J].

Li, Ye ;

Hermanson, David L. ;

Moriarity, Branden S. ;

Kaufman, Dan S. .

CELL STEM CELL, 2018, 23 (02) :181-+

[47] First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma [J].

Liau, Linda M. ;

Ashkan, Keyoumars ;

Tran, David D. ;

Campian, Jian L. ;

Trusheim, John E. ;

Cobbs, Charles S. ;

Heth, Jason A. ;

Salacz, Michael ;

Taylor, Sarah ;

D'andre, Stacy D. ;

Iwamoto, Fabio M. ;

Dropcho, Edward J. ;

Moshel, Yaron A. ;

Walter, Kevin A. ;

Pillainayagam, Clement P. ;

Aiken, Robert ;

Chaudhary, Rekha ;

Goldlust, Samuel A. ;

Bota, Daniela A. ;

Duic, Paul ;

Grewal, Jai ;

Elinzano, Heinrich ;

Toms, Steven A. ;

Lillehei, Kevin O. ;

Mikkelsen, Tom ;

Walpert, Tobias ;

Abram, Steven R. ;

Brenner, Andrew J. ;

Brem, Steven ;

Ewend, Matthew G. ;

Khagi, Simon ;

Portnow, Jana ;

Kim, Lyndon J. ;

Loudon, William G. ;

Thompson, Reid C. ;

Avigan, David E. ;

Fink, Karen L. ;

Geofroy, Francois J. ;

Lindhorst, Scott ;

Lutzky, Jose ;

Sloan, Andrew E. ;

Schackert, Gabriele ;

Krex, Dietmar ;

Meisel, Hans-Jorg ;

Wu, Julian ;

Davis, Raphael P. ;

Duma, Christopher ;

Etame, Arnold B. ;

Mathieu, David ;

Kesari, Santosh .

JOURNAL OF TRANSLATIONAL MEDICINE, 2018, 16 :1

[48] Current state of immunotherapy for glioblastoma [J].

Lim, Michael ;

Xia, Yuanxuan ;

Bettegowda, Chetan ;

Weller, Michael .

NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (07) :422-442

[49] B7-H1-Dependent Sex-Related Differences in Tumor Immunity and Immunotherapy Responses [J].

Lin, Pei-Yi ;

Sun, Lishi ;

Thibodeaux, Suzanne R. ;

Ludwig, Sara M. ;

Vadlamudi, Ratna K. ;

Hurez, Vincent J. ;

Bahar, Rumana ;

Kious, Mark J. ;

Livi, Carolina B. ;

Wall, Shawna R. ;

Chen, Lieping ;

Zhang, Bin ;

Shin, Tahiro ;

Curiel, Tyler J. .

JOURNAL OF IMMUNOLOGY, 2010, 185 (05) :2747-2753

[50] A Phase 1 Trial of Oncolytic HSV-1, G207, Given in Combination With Radiation for Recurrent GBM Demonstrates Safety and Radiographic Responses [J].

Markert, James M. ;

Razdan, Shantanu N. ;

Kuo, Hui-Chien ;

Cantor, Alan ;

Knoll, Anette ;

Karrasch, Matthias ;

Nabors, L. Burt ;

Markiewicz, Michael ;

Agee, Bonita S. ;

Coleman, Jennifer M. ;

Lakeman, Alfred D. ;

Palmer, Cheryl A. ;

Parker, Jacqueline N. ;

Whitley, Richard J. ;

Weichselbaum, Ralph R. ;

Fiveash, John B. ;

Gillespie, G. Yancey .

MOLECULAR THERAPY, 2014, 22 (05) :1048-1055

← 1 2 3 4 5 6 7 8 9 10 →